tm logo
TEVACANN
Live/Pending
FINAL REFUSAL - MAILED

mailed

on 09 Mar 2024

Last Applicant/ Owned by

124 Dvora HaNevi'a St.,

Tel Aviv

IL

6944020

Serial Number

97253500 filed on 04th Feb 2022

Registration Number

N/A

Correspondent Address

Laurence Rickles

TEVA PHARMACEUTICALS USA, INC.

400 INTERPACE PARKWAY

BUILDING A

PARSIPPANY,NJ 07054

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

TEVACANN

Vaporizers for medical purposes Providing medical information relating to products containing cannabis Cannabis based preparations for human use and products containing cannabis for human use namely, oral drops for pain, medicated oils; dietary suppelments; all of the foregoing good that contain hemp and CBD are derived from hemp with a delta-9 tetrahydracannibinol (THC) concentration of not morRead More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Providing medical information relating to products containing cannabis

Class [010]
Medical Instrument Products


Vaporizers for medical purposes

Class [005]
Pharmaceutical Products


Cannabis based preparations for human use and products containing cannabis for human use namely, oral drops for pain, medicated oils; dietary suppelments; all of the foregoing good that contain hemp and CBD are derived from hemp with a delta-9 tetrahydracannibinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Mark Details


Serial Number

No 97253500

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Mar 2024FINAL REFUSAL WRITTEN
09th Mar 2024FINAL REFUSAL E-MAILED
09th Mar 2024NOTIFICATION OF FINAL REFUSAL EMAILED
26th Jun 2023ASSIGNED TO EXAMINER
23rd Jun 2023ASSIGNED TO EXAMINER
09th Jun 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
09th Jun 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
09th Jun 2023TEAS/EMAIL CORRESPONDENCE ENTERED
20th Mar 2023ASSIGNED TO EXAMINER
20th Mar 2023NON-FINAL ACTION WRITTEN